Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many patients experience a slowdown in weight loss after approximately 12 months of Wegovy use, even while taking the medication consistently. This plateau is not a failure of the drug—it reflects how the body adapts to GLP-1 receptor activation over time. Understanding the biology behind weight loss stalls and exploring personalized treatment options can help you move past a plateau and continue toward your goals.
What Happens to Your Body After a Year of GLP-1 Use
The human body is remarkably adaptive. When you take semaglutide daily or weekly, your GLP-1 receptors—the key proteins that control hunger and blood sugar—become less responsive to repeated stimulation. This process, called receptor desensitization, is a normal physiological response that occurs with many medications. After 12 months, some patients notice their appetite returns slightly or their weight loss speed decreases, even though they are following the same dose.
Research shows that initial weight loss on GLP-1 medications is often most dramatic in the first 6 to 12 months. As your body adjusts, additional losses may slow but do not stop entirely. The medication continues to work—your nervous system and metabolic rate have simply adapted to the new baseline. This is why ongoing medical supervision and occasional dose adjustments become important for sustained progress.
Genetic Factors That Shape Your GLP-1 Response
Not everyone responds to semaglutide in the same way or at the same speed. Your genetic makeup influences how effectively your GLP-1 receptors function and how your brain processes hunger signals. Specific genetic variants—such as those in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609)—can predict whether you are a strong responder, moderate responder, or may benefit from a different peptide compound altogether. These differences exist from birth and explain why some patients lose 30 pounds while others lose 60 on identical doses.
PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 150+ genetic insights to show how your body processes GLP-1 compounds and related peptides. This $99 test (added after your first month of treatment) can reveal whether semaglutide is optimal for your biology or whether a dual-compound approach or oral formulation might be more effective. Understanding your genetic peptide profile removes guesswork from weight loss medicine.
When to Increase Your Dose or Switch Medications
If your weight loss has plateaued for 4 or more weeks despite consistent medication use and unchanged eating and activity patterns, a dose increase or medication change may be appropriate. Your PlexusDx provider can evaluate whether your current semaglutide dose should increase to the next tier, or whether switching to tirzepatide (a dual GIP/GLP-1 receptor agonist) might restart progress. Tirzepatide activates two hunger-control pathways instead of one, making it effective for patients who have adapted to semaglutide alone. Some patients also benefit from PlexusDx's GLP-Squared Injection, which combines both compounds for amplified effect.
The key principle behind PlexusDx pricing is that your dose may need to go up, but your price won't. Whether you start on Compounded Semaglutide Injection at $149/month or increase your dose, you maintain the same monthly cost across commitment tiers. This removes the financial barrier to dose optimization, ensuring you can access higher concentrations if your provider recommends it without unexpected price increases.
Beyond Medication: Lifestyle Factors That Prevent Stalls
Weight loss plateaus are sometimes amplified by lifestyle factors that medications alone cannot overcome. Reduced physical activity, increasing calorie intake as appetite suppression lessens, sleep deprivation, and chronic stress all slow metabolic rate and can counteract GLP-1 therapy. A plateau may be a signal to reassess your nutrition strategy, increase exercise intensity, or address sleep quality. Many patients find that a brief nutrition consultation or fitness adjustment reignites progress without needing medication changes.
Plateaus are also mathematically inevitable at healthy weights. If you have lost 40 pounds and are approaching a stable body composition, further losses naturally slow because your body requires fewer total calories to maintain a lower weight. This is healthy adaptation, not medication failure. Your provider can help you distinguish between a true therapeutic plateau requiring intervention and a natural slowing that reflects progress toward your target weight.
Why Compounded Semaglutide Offers Flexibility During Plateaus
Compounded semaglutide from licensed 503A pharmacies gives you dosing flexibility that brand-name Wegovy does not. Because PlexusDx formulations are custom-mixed, your provider can adjust your exact dose without moving to a new pre-filled pen or facing supply constraints. This means faster response times when a plateau develops and more precise titration to find your optimal therapeutic dose. Compounded options also cost less—starting at $149/month for Compounded Semaglutide Injection—while maintaining the same pharmaceutical standards as brand-name versions.
PlexusDx serves all 50 states without insurance requirements or membership fees, making it accessible regardless of your plan. Your medication is HSA/FSA eligible, reducing out-of-pocket costs further. When you hit a plateau and need to adjust course, you're not locked into waiting for a prescription refill or fighting insurance approval delays—your provider can modify your regimen immediately.
The Role of Continuous Monitoring in Breaking Through Plateaus
Successful long-term weight loss on GLP-1 therapy requires regular check-ins with your prescriber to monitor progress, side effects, and response trends. Patients who plateau often benefit from switching their monitoring schedule from monthly to bi-weekly visits to catch and respond to stalls quickly. Your provider can evaluate your food intake logs, activity level, sleep quality, and medication adherence to pinpoint the cause of a slowdown. Sometimes a plateau signals the need for a medication change; other times it reflects an adjustment period before progress resumes.
PlexusDx providers use your genetic insights from the Precision Peptide Genetic Test to refine your treatment plan scientifically. If your genetic profile shows you have variants associated with moderate GLP-1 receptor sensitivity, your provider may proactively recommend tirzepatide or a dual-compound approach before you plateau, setting you up for sustained results. This precision approach turns plateau risk into an opportunity for personalized optimization.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does Wegovy stop working after one year?
Wegovy does not stop working, but your body adapts to it through receptor desensitization. Weight loss typically slows after 12 months rather than stopping completely. A dose increase, medication switch (such as to tirzepatide), or lifestyle adjustment often restarts progress. PlexusDx providers can customize your treatment plan to move past a plateau.
What is the difference between semaglutide and tirzepatide for weight loss?
Semaglutide activates the GLP-1 receptor to reduce hunger and slow digestion. Tirzepatide activates both GLP-1 and GIP receptors, targeting two hunger-control pathways simultaneously. Tirzepatide is often more effective for patients who plateau on semaglutide alone. PlexusDx offers both as compounded injections, with tirzepatide starting at $249/month.
How much does compounded semaglutide cost at PlexusDx?
Compounded Semaglutide Injection from PlexusDx starts at $149/month flat—your dose may increase, but your price won't. The medication is HSA/FSA eligible, available in all 50 states without insurance, and comes from licensed 503A compounding pharmacies. No membership or hidden fees apply.
Is the Precision Peptide Genetic Test worth getting?
Yes, if you are considering switching medications or want to understand why you may respond differently to GLP-1 therapy than others. The $99 test (added after your first month) analyzes 14 pathways and 150+ genetic insights, revealing your peptide profile and predicting which compounds—semaglutide, tirzepatide, or combinations—align best with your biology.
Can I switch from semaglutide to tirzepatide without starting over?
Yes. PlexusDx providers can transition you from semaglutide to tirzepatide or to GLP-Squared (a dual-compound injection combining both) without restarting a titration schedule. A genetic test result or plateau pattern often guides this decision. Tirzepatide Injection starts at $249/month, maintaining transparent, flat monthly pricing.
What should I do if my weight loss has stalled for 6 weeks?
Contact your PlexusDx provider to review your dose, medication choice, nutrition, activity, and sleep. A genetic test (if not done previously) can reveal whether a compound switch would help. Your provider may increase your semaglutide dose, recommend tirzepatide, or suggest lifestyle adjustments—all without pricing penalties under PlexusDx's flat-rate model.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Avoid Side Effects of Wegovy
Is the Skinny Shot the Same as Ozempic?